CLINICAL STUDIES

 
Islet Allotransplantation for patients with T1DM

A Safety, Tolerability and Efficacy Study of Sernova’s Cell Pouch™  for Clinical Islet Transplantation.

​

Funded by JDRF/Sernova

OPEN ENROLLMENT

Islet Transplantation in Patients with “Brittle” Type 1 Diabetes

 

Internal Funding 

Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients

 

Internal Funding 

COMPLETED

RESULTS >>

Allogenic Islet Cells (Human. U. of Chicago) Administered via Intraportal Infusion and Immunosuppressive Therapy.

​

Funded by the State of Illinois

COMPLETED

A Phase 3, Multicenter, Randomized, Double-blind, Parallel Assignment Study to Assess The Efficacy and Safety of Reparixin in Pancreatic Islet Transplantation (REP0211).

​

Funded by DOMPE Pharmaceutical..